ScholarIQanswers from OpenAlex & ORCID
Filip Jankú
ResearcherPublications, citations & collaboration network
Filip Jankú is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Filip Jankú have?
ScholarIQindexed works
Filip Jankú has 1,016 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Filip Jankú have?
ScholarIQcitation count
Filip Jankú has 27,226 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Filip Jankú?
ScholarIQh-index
Filip Jankú has an h-index of 80 in OpenAlex.
What is the i10-index of Filip Jankú?
ScholarIQi10-index
Filip Jankú has an i10-index of 284 in OpenAlex.
What is the ORCID of Filip Jankú?
ScholarIQorcid
The ORCID for Filip Jankú is on the source record.
What is the OpenAlex record for Filip Jankú?
ScholarIQopenalex
The OpenAlex for Filip Jankú is on the source record.
What are the most-cited papers on Filip Jankú?
ScholarIQmost cited works
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
Jean‐François Emile, Oussama Abla, Sylvie Fraitag, AnnaCarin Horne, Julien Haroche, Jean Donadieu, Luis Requena‐Caballero, Michael B. Jordan, Omar Abdel‐Wahab, Carl E. Allen, Frédéric Charlotte, Eli L. Diamond, R. Maarten Egeler, Alain Fischer, Juana Gil Herrera, Jan‐Inge Henter, Filip Jankú, Miriam Mérad, Jennifer Picarsic, Carlos Rodríguez‐Galindo, Barret J. Rollins, Abdellatif Tazi, Robert Vassallo, Lawrence M. Weiss
Phase II Pilot Study of Vemurafenib in Patients With Metastatic <i>BRAF</i> -Mutated Colorectal Cancer
Scott Kopetz, Jayesh Desai, Emily Chan, J. Randolph Hecht, Peter J. O’Dwyer, Dipen M. Maru, Van K. Morris, Filip Jankú, Arvind Dasari, Woonbok Chung, Jean‐Pierre J. Issa, Peter Gibbs, Brian P. James, Garth Powis, K. B. Nolop, Suman Bhattacharya, Leonard B. Saltz
Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative
Apostolia M. Tsimberidou, Nancy G. Iskander, David S. Hong, Jennifer J. Wheler, Gerald S. Falchook, Siqing Fu, Sarina A. Piha‐Paul, Aung Naing, Filip Jankú, Rajyalakshmi Luthra, Ye Yang, Sijin Wen, Donald A. Berry, Razelle Kurzrock
Intratumoral injection of <i>Clostridium novyi</i> -NT spores induces antitumor responses
Nicholas J. Roberts, Linping Zhang, Filip Jankú, Amanda Collins, Ren-Yuan Bai, Verena Staedtke, Anthony Rusk, David Tung, Maria Miller, Jeffrey J. Roix, Kristen V. Khanna, Ravi Murthy, Robert S. Benjamin, Thorunn Helgason, Ariel D. Szvalb, Justin E. Bird, Sinchita Roy‐Chowdhuri, Halle H. Zhang, Yuan Qiao, Baktiar Karim, Jennifer S. McDaniel, Amanda Elpiner, Alexandra Sahora, Joshua L. Lachowicz, Brenda Phillips, Avenelle I. Turner, Mary K. Klein, Gerald Post, Luis A. Díaz, Gregory J. Riggins, Nickolas Papadopoulos, Kenneth W. Kinzler, Bert Vogelstein, Chetan Bettegowda, David L. Huso, Mary Varterasian, Saurabh Saha, Shibin Zhou
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial
Ingo K. Mellinghoff, Marta Peñas-Prado, Katherine B. Peters, Howard A. Burris, Elizabeth A. Maher, Filip Jankú, Gregory M. Coté, Macarena I. de la Fuente, Jennifer Clarke, Benjamin M. Ellingson, Saewon Chun, Robert J. Young, Hua Liu, Sung Choe, Min Lu, Kha Le, Islam Hassan, Lori Steelman, Shuchi S. Pandya, Timothy F. Cloughesy, Patrick Y. Wen